LONDON (Alliance News) - CVS Group PLC on Thursday increased its shareholder payout as it reported a large rise in annual revenue and lobbied the UK government to mitigate adverse employment impacts post-Brexit.
The veterinary service provider increased revenue by 20% to GBP327.3 million from GBP271.8 million. The growth in revenue stems from the company acquiring 52 surgeries in the period.
In the twelve months ended June, CVS' pretax profit decreased 2.8% to GBP14.1 million from GBP14.5 million the year before. CVS said the small decrease was due to the GBP1.8 million increase in amortisation costs as a result of prior year acquisitions.
The company's Veterinary Practices division increased its profit by 20% to GBP297.5 million from GBP247.9 million, with like-for-like sales increasing 3.0%.
CVS proposed a 5.0 pence dividend for the year, up 11% from the 4.5p payout last year.
The company believes its outlook is "very promising" as like-for-like sales growth has remained "robust" since the year-end.
CVS said its potential exposure to Brexit "appears to be limited" but the greatest impact could be in the employment of European vets.
Along with the Royal College of Veterinary Surgeons, the company is lobbying the UK government to "mitigate against any such potential adverse impacts".
Shares in CVS were down 4.0% Thursday at 982.50 pence each.


(Alliance News) - Kelso Group Holdings PLC on Friday said it has bought shares in Capita PLC in recent weeks, as the London-based investor in UK liste...


(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday.


(Sharecast News) - Veterinary services provider CVS Group said on Tuesday that it has successfully refinanced its bank debt facilities, as it announce...


LONDON BROKER RATINGS: Barclays ups Hochschild Mining after price fall


UK shareholder meetings calendar - next 7 days


IN BRIEF: CVS Group CFO Robin Alfonso buys GBP50,000 in shares


LONDON BROKER RATINGS: Barclays raises Ascential; HSBC upgrades Pennon


(Sharecast News) - Analysts at RBC Capital Markets has raised their target price on veterinary services provider CVS Group from 2,750.0p to 3,100.0p.


LONDON BROKER RATINGS: Morgan Stanley upgrades Centrica to Overweight


LONDON MARKET CLOSE: Cautious end to week as Evergrande worries linger


CVS Group's GBP20 million vet chain acquisition probed by regulator